| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 5.78B | 5.57B | 5.48B | 4.98B | 4.67B |
| Gross Profit | 2.10B | 2.09B | 2.04B | 1.80B | 1.75B |
| EBITDA | 678.00M | 846.00M | 875.00M | 779.00M | 840.00M |
| Net Income | 164.00M | 319.00M | 367.00M | 348.00M | 422.00M |
Balance Sheet | |||||
| Total Assets | 3.97B | 4.01B | 3.63B | 3.56B | 3.64B |
| Cash, Cash Equivalents and Short-Term Investments | 342.00M | 217.00M | 182.00M | 237.00M | 173.00M |
| Total Debt | 2.45B | 2.57B | 2.27B | 2.25B | 2.27B |
| Total Liabilities | 3.17B | 3.25B | 4.36B | 4.28B | 2.89B |
| Stockholders Equity | 798.00M | 752.00M | 926.22M | -720.00M | 746.00M |
Cash Flow | |||||
| Free Cash Flow | 534.00M | 544.00M | 623.00M | 689.00M | 395.00M |
| Operating Cash Flow | 673.00M | 675.00M | 746.00M | 782.00M | 491.00M |
| Investing Cash Flow | 11.00M | -254.00M | -118.00M | -87.00M | -85.00M |
| Financing Cash Flow | -560.00M | -384.00M | -680.00M | -634.00M | -450.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | £1.73B | 7.84 | 15.61% | 1.62% | 2.31% | 9.04% | |
73 Outperform | £28.38B | 16.76 | 16.05% | 3.25% | 5.43% | 15.57% | |
71 Outperform | £1.88B | 11.45 | 21.74% | 17.38% | 3.66% | -48.66% | |
71 Outperform | £8.04B | 17.63 | 17.21% | 3.56% | 0.59% | -5.46% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
60 Neutral | £1.56B | 3.79 | 24.47% | ― | ― | ― | |
56 Neutral | £6.66B | 17.81 | 6.12% | 4.02% | 2.54% | 12.99% |